---

---

sector : Manufacturing    crawled date : 2022 - 11 - 10   

save search

---

Regen BioPharma Developing a Non-Exhaustible CAR-T Cell Therapeutic
Published: 2022-11-10 (Crawled : 23:00) - prnewswire.com
RGBP | $0.7 5.69% 11K |

Manufacturing

| 12730.19% | O: -1.89% H: 7.69% C: 1.92%
biopharma car-t

---

IntelGenx Reschedules Third Quarter 2022 Conference Call Due to Technical Issues Experienced Today by Webcast Vendor
Published: 2022-11-10 (Crawled : 23:00) - globenewswire.com
IGXT | $0.17 -19.77% 73K |

Manufacturing

| 3.28% | O: -2.79% H: 5.94% C: 5.94%
conference today

---

Centessa Pharmaceuticals Facing Investigation by National Securities Law Firm Over Alleged Misleading Statements
Published: 2022-11-10 (Crawled : 21:00) - prnewswire.com
CNTA | $10.555 0.24% 0.24% 150K |

Manufacturing

| 205.49% | O: 1.45% H: 4.99% C: 1.14%
pharmaceuticals

---

LiveOnNY Announces the Hire of Abraham Warshaw, MD, As Chief Medical Officer
Published: 2022-11-10 (Crawled : 21:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M |

Manufacturing

| 37.22% | O: 4.39% H: 0.0% C: 0.0%

---

GT Biopharma Presents Two Posters at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
Published: 2022-11-10 (Crawled : 21:00) - globenewswire.com
GTBP | $3.8001 1.3% 5.9K |

Manufacturing

| 76.56% | O: 0.24% H: 4.53% C: 1.67%
biopharma immunotherapy meeting cancer

---

Stem Holdings Announces Offering
Published: 2022-11-10 (Crawled : 21:00) - globenewswire.com
STMH | $0.1 -88.3% 2.2K |

Manufacturing

| 233.33% | O: 3.0% H: 0.0% C: 0.0%
offering

---

Hoag Announces $300 Million Boldly Hoag Capital Campaign
Published: 2022-11-10 (Crawled : 20:00) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M |

Manufacturing

| 37.22% | O: 4.39% H: 0.0% C: 0.0%

---

Earth Science Tech, Inc. (ETST) Announces Second Quarter Fiscal 2023 Financial Results on November 14, 2022, Followed with an Updated Conference Call and Webcast
Published: 2022-11-10 (Crawled : 19:00) - globenewswire.com
ETST P | $0.068 -67.14% 43K |

Manufacturing

| 37.61% | O: 12.39% H: 0.0% C: -8.16%
conference financial results

---

Oil Country Tubular Goods Market Report 2022: Growing Global Offshore Rig Count and Exploration of Resources Fueling Sector
Published: 2022-11-10 (Crawled : 18:00) - prnewswire.com
AMSIY | $0.1305 0 |

Manufacturing

| -32.45% | O: -7.35% H: 0.0% C: 0.0%
MT | $25.39 0.95% 0.0% 1.3M |

Non-Energy Minerals

| 5.57% | O: 2.58% H: 2.59% C: 2.31%
global report growing market

---

Schneider Electric Square D™ Energy Center Named to TIME's List of the Best Inventions of 2022
Published: 2022-11-10 (Crawled : 16:00) - prnewswire.com
SBGSF | $230.0 0.82% 3.2K |

Producer Manufacturing

| 67.3% | O: 7.23% H: 0.0% C: -1.09%
SBGSY | $45.56 -1.39% 170K |

Manufacturing

| 66.44% | O: 5.89% H: 1.77% C: 1.45%
energy

---

Todos Medical Terminates Tollovid™ Products License & Distribution Agreement with T-Cell Protect Hellas S.A.
Published: 2022-11-10 (Crawled : 16:00) - globenewswire.com
TOMDF | $0.0001 100.0% 14M |

Manufacturing

| -98.4% | O: 2.4% H: 0.0% C: -6.25%
t-cell distribution license agreement

---

InspiraTM Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRATM ART System
Published: 2022-11-10 (Crawled : 15:00) - biospace.com/
IINN | $1.83 1.11% 1.1% 91K |

Manufacturing

| 56.29% | O: 1.59% H: 10.26% C: 4.14%
patent system granted

---

11/10/22 – RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company’s CFO is presenting at the Investor Summit Q4
Published: 2022-11-10 (Crawled : 15:00) - respirerx.com
RSPI | $0.0008 0.0% 600K |

Manufacturing

| Email alert Add to watchlist
pharmaceuticals

---

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2023 Financial Results and Recent Updates
Published: 2022-11-10 (Crawled : 15:00) - biospace.com/
ANEB | $2.85 -7.14% 710 |

Manufacturing

| 9.02% | O: 7.76% H: 0.0% C: -9.75%
pharmaceuticals year financial results

---

Adagene Announces Clinical Data at SITC 2022 on Anti-CTLA-4 NEObody™, ADG116, Showing Differentiated Safety and Anti-tumor Activity in Heavily Pre-treated Patients with Difficult-to-Treat Tumors
Published: 2022-11-10 (Crawled : 14:20) - globenewswire.com
ADAG | $2.63 -0.38% -0.38% 5.4K |

Manufacturing

| 182.9% | O: -2.4% H: 9.79% C: 4.3%
adg116 tumors

---

Lightwave Logic Provides Third Quarter 2022 Corporate Update
Published: 2022-11-10 (Crawled : 14:00) - prnewswire.com
LWLG | $4.02 -1.95% -1.99% 770K |

Manufacturing

| -42.82% | O: 7.68% H: 13.08% C: 8.06%
update

---

Aimmune Therapeutics to Present Positive Results from Phase 3 POSEIDON Study of PALFORZIA® [Peanut (Arachis hypogaea) Allergen Powder-dnfp] in Peanut-Allergic Children Aged 1 to 3 Years
Published: 2022-11-10 (Crawled : 14:00) - biospace.com/
IMUN | $0.093 214.52% 1.8K |

Manufacturing

| -91.98% | O: -13.79% H: 0.0% C: 0.0%
palforzia children therapeutics positive results study

---

Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2022 and Provides Corporate Update
Published: 2022-11-10 (Crawled : 14:00) - globenewswire.com
FEMY | $1.33 1.53% 1.5% 160K |

Manufacturing

| 12.82% | O: 4.27% H: 6.56% C: 1.64%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -15.07% | O: 0.18% H: 0.0% C: 0.0%
financial update

---

RespireRx Pharmaceuticals Inc. Announces that Jeff Margolis, the Company’s CFO is presenting at the Investor Summit Q4
Published: 2022-11-10 (Crawled : 14:00) - globenewswire.com
RSPI | $0.0008 0.0% 600K |

Manufacturing

| Email alert Add to watchlist
pharmaceuticals

---

Altamira Therapeutics to Participate at TIDES Europe Oligonucleotide and Peptide Therapeutics Hybrid Event
Published: 2022-11-10 (Crawled : 14:00) - globenewswire.com
CYTO | $1.5 -7.95% 46K |

Manufacturing

| -73.04% | O: 4.02% H: 2.39% C: -4.04%
europe therapeutics

---

Gainers vs Losers

67%

33%

Top 10 Gainers

---

Your saved searches

---